Page last updated: 2024-10-24

chlorambucil and Facial Dermatoses

chlorambucil has been researched along with Facial Dermatoses in 2 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Facial Dermatoses: Skin diseases involving the FACE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Niaimi, F1
Cox, NH1
Taylor, WD1
Goon, AT1
McFadden, JP1
McCann, M1
Royds, C1
Rycroft, RJ1

Other Studies

2 other studies available for chlorambucil and Facial Dermatoses

ArticleYear
Follicular hyperkeratosis as a manifestation of Sézary syndrome.
    The British journal of dermatology, 2010, Volume: 162, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Chlorambucil; Diagnosis, Differential; Facial Dermatoses; Humans;

2010
Allergic contact dermatitis from melphalan and chlorambucil: cross-sensitivity or cosensitization?
    Contact dermatitis, 2002, Volume: 47, Issue:5

    Topics: Adult; Allergens; Chlorambucil; Cross Reactions; Dermatitis, Allergic Contact; Dermatitis, Occupatio

2002